Cargando…
Cell therapies for pancreatic beta-cell replenishment
The current treatment approach for type 1 diabetes is based on daily insulin injections, combined with blood glucose monitoring. However, administration of exogenous insulin fails to mimic the physiological activity of the islet, therefore diabetes often progresses with the development of serious co...
Autores principales: | Okere, Bernard, Lucaccioni, Laura, Dominici, Massimo, Iughetti, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940879/ https://www.ncbi.nlm.nih.gov/pubmed/27400873 http://dx.doi.org/10.1186/s13052-016-0273-4 |
Ejemplares similares
-
The “perfect” storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic
por: Lami, Francesca, et al.
Publicado: (2020) -
Long term outcomes of infants born by mothers with thyroid dysfunction during pregnancy
por: Lucaccioni, Laura, et al.
Publicado: (2021) -
Perinatal Exposure to Phthalates: From Endocrine to Neurodevelopment Effects
por: Lucaccioni, Laura, et al.
Publicado: (2021) -
Endocrine Disrupting Chemicals and Type 1 Diabetes
por: Predieri, Barbara, et al.
Publicado: (2020) -
Neurotransmitter Release Site Replenishment and Presynaptic Plasticity
por: Mochida, Sumiko
Publicado: (2020)